Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 2, 2006, Pages 192-194

  Roemeling, S ^a   van Leenders, G J L H ^a   Schroder F H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Local neoplasm recurrence; Prostate specific antigen; Prostatic neoplasm; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; DELAYED DIAGNOSIS; DIAGNOSTIC ERROR; DIGITAL RECTAL EXAMINATION; FOLLOW UP; GLEASON SCORE; HUMAN; MALE; MEDICAL DECISION MAKING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE SURGERY;

AGED; BIOPSY, NEEDLE; BRACHYTHERAPY; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 33745639658     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500861     Document Type: Article

References (11)

1. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-916.
2. Oh J, Colberg JW, Ornstein DK, Johnson ET, Chan D, Virgo KS et al. Current follow up strategies after radical prostatectomy: A survey of American Urological Association Urologists. J Urol 1999; 161: 520-523.
3. Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol 1999; 162: 1337-1340.
4. Gleason DF. Histologic grading of prostate cancer: A perspective. Hum Pathol 1992; 23: 273-279.
5. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 129-138.
6. Goldrath DE, Messing EM. Prostate specific antigen: Not detectable despite tumor progression after radical prostatectomy. J Urol 1989; 142: 1082-1084.
7. Oefelein MG, Smith N, Carter M, Dalton D, Schaeffer A. The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J Urol 1995; 154: 2128-2131.
8. Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: The implications for follow-up. Eur Urol 2005; 48: 906-910.
9. Leibman BD, Dillioglugil O, Wheeler TM, Scardino PT. Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level. Cancer 1995; 76: 2530-2534.
10. Takayama TK, Krieger JN, True LD, Lange PH. Recurrent prostate cancer despite undetectable prostate specific antigen. J Urol 1992; 148: 1541-1542.
11. Stege RH, Tribukait B, Carlstrom KA, Grande M, Pousette AH. Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy. Prostate 1999; 38: 183-188.